Tomoyuki Kawamura

7PUBLICATIONS
42CO-AUTHORS
Population trends and policiesDisease surveillancePharmacogenomicsTraditional Chinese medicine and treatmentsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 30, 2026
Renal function trajectories before and during the COVID-19 pandemic in Japanese individuals with type 1 diabetes: a post-hoc analysis of the multicenter retrospective investigation by the IPRA-CKD study group.

|Aug 19, 2026
Observational study of the relationship between the use of real-time continuous glucose monitoring and glycemic control in patients with diabetes in Japan: the REALJ study.

|Nov 18, 2025
Diabetic Ketoacidosis and Severe Hypoglycemia Risks with Ipragliflozin/Insulin Versus Insulin in Type 1 Diabetes: A Japanese Real-World Database Study.

Tomoyuki Kawamura, Takumi Lee, Mami Shintani-Tachi

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

|Jul 23, 2020
Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.

Eiji Kawasaki, Yoichi Oikawa, Akira Okada

|Mar 17, 2020
Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.

Eiji Kawasaki, Yoichi Oikawa, Akira Okada

Pageof 2

Frequent Collaborators

3 joint publications

Eiji Kawasaki

3 joint publications

Junnosuke Miura

3 joint publications

Yushi Hirota

3 joint publications

Yoshihiko Yuyama